Aspen Neuroscience trust converts preferred shares

Q: How many ASPE common shares were reported in the preferred-stock conversion?

The reported common-stock amounts were 14,913 shares for Series A-1, 14,316 for Series A-2 and 7,120 for Series C Convertible Preferred Stock.

Q: What conversion ratio applied to ASPE’s preferred stock?

The preferred stock automatically converted on a 1-for-9.8821 basis into common stock upon closing of the initial public offering, without payment of further consideration.

The conversion required no further consideration and occurred on a 1-for-9.8821 basis.

Available on EDGAR 11/02/2026 - 09:04 PM EST Accepted by SEC EDGAR 11/02/2026 - 09:03 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Aspen Neuroscience, Inc. (ASPE) reported that the Hasnain Revocable Trust’s Series A-1, Series A-2 and Series C Convertible Preferred Stock automatically converted into common stock upon closing of the company’s initial public offering on November 2, 2026. The reported common-stock amounts were 14,913, 14,316 and 7,120 shares, respectively, on a 1-for-9.8821 basis, without payment of further consideration. Separately, Executive Chair Faheem Hasnain is listed with 26,658 directly held common shares.

Insider Trade Summary

36,349 shares exercised/converted

Exercise 6 txns

Insider Hasnain Faheem

Role Executive Chair

Type	Security	Shares	Price	Value
Conversion	Series A-1 Convertible Preferred Stock ^{F1, F2}	14,913	--	--
Conversion	Series A-2 Convertible Preferred Stock ^{F1, F2}	14,316	--	--
Conversion	Series C Convertible Preferred Stock ^{F1, F2}	7,120	--	--
Conversion	Common Stock ^{F1, F2}	14,913	--	--
Conversion	Common Stock ^{F1, F2}	14,316	--	--
Conversion	Common Stock ^{F1, F2}	7,120	--	--
Holding	Common Stock	--	--	--

Holdings After Transaction: Series A-1 Convertible Preferred Stock — 0 contracts (Indirect, See Footnote 2.); Series A-2 Convertible Preferred Stock — 0 contracts (Indirect, See Footnote 2.); Series C Convertible Preferred Stock — 0 contracts (Indirect, See Footnote 2.); Common Stock — 7,120 shares (Indirect, See Footnote 2.); Common Stock — 26,658 shares (Direct)

Holdings Before and After: Series A-1 Convertible Preferred Stock, 14,913 to 0 contracts (Indirect, See Footnote 2.); Series A-2 Convertible Preferred Stock, 14,316 to 0 contracts (Indirect, See Footnote 2.); Series C Convertible Preferred Stock, 7,120 to 0 contracts (Indirect, See Footnote 2.)

Footnotes (2)

F1. Each share of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, and Series C Convertible Preferred Stock (collectively, the "Preferred Stock") automatically converted on a 1-for-9.8821 basis into shares of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock had no expiration date.
F2. Securities held by the Hasnain Revocable Trust.

Key Figures

Series A-1 common-stock amount reported: 14,913 shares Series A-2 common-stock amount reported: 14,316 shares Series C common-stock amount reported: 7,120 shares +2 more

5 metrics

Series A-1 common-stock amount reported 14,913 shares Preferred-stock conversion on November 2, 2026

Series A-2 common-stock amount reported 14,316 shares Preferred-stock conversion on November 2, 2026

Series C common-stock amount reported 7,120 shares Preferred-stock conversion on November 2, 2026

Conversion basis 1-for-9.8821 Preferred stock converted into common stock

Faheem Hasnain direct common shares 26,658 shares Holding entry dated November 2, 2026

Key Terms

Convertible Preferred Stock, 1-for-9.8821 basis, initial public offering

3 terms

Convertible Preferred Stock financial

"Series A-1 Convertible Preferred Stock"

Convertible preferred stock is a special class of company shares that pays priority, usually fixed, payments to holders and can be exchanged later for a set number of common shares. It matters to investors because it combines steady income and added protection with the chance to share in a company’s upside; think of it as a hybrid between a bond that pays regularly and an option to convert into growth-oriented stock, where the conversion rules influence both potential gains and how much common shareholders’ ownership may be reduced.

1-for-9.8821 basis financial

"converted on a 1-for-9.8821 basis"

initial public offering financial

"closing of the Issuer's initial public offering"

An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ASPE common shares were reported in the preferred-stock conversion?

The reported common-stock amounts were 14,913 shares for Series A-1, 14,316 for Series A-2 and 7,120 for Series C Convertible Preferred Stock.

What conversion ratio applied to ASPE’s preferred stock?

The preferred stock automatically converted on a 1-for-9.8821 basis into common stock upon closing of the initial public offering, without payment of further consideration.

How many ASPE common shares did Faheem Hasnain hold directly?

A separate holding entry lists Executive Chair Faheem Hasnain with 26,658 common shares held directly on November 2, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hasnain Faheem

(Last)

(First)

(Middle)

C/O ASPEN NEUROSCIENCE, INC.

10835 ROAD TO THE CURE, SUITE 100

(Street)

SAN DIEGO

CALIFORNIA

92121

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Aspen Neuroscience, Inc. [ ASPE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Executive Chair

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/02/2026		C		14,913	A	⁽¹⁾	14,913	I	See Footnote 2.⁽²⁾
Common Stock	11/02/2026		C		14,316	A	⁽¹⁾	14,316	I	See Footnote 2.⁽²⁾
Common Stock	11/02/2026		C		7,120	A	⁽¹⁾	7,120	I	See Footnote 2.⁽²⁾
Common Stock								26,658	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Series A-1 Convertible Preferred Stock	⁽¹⁾	11/02/2026		C			14,913	⁽¹⁾	⁽¹⁾	Common Stock	14,913	⁽¹⁾	0	I	See Footnote 2.⁽²⁾
Series A-2 Convertible Preferred Stock	⁽¹⁾	11/02/2026		C			14,316	⁽¹⁾	⁽¹⁾	Common Stock	14,316	⁽¹⁾	0	I	See Footnote 2.⁽²⁾
Series C Convertible Preferred Stock	⁽¹⁾	11/02/2026		C			7,120	⁽¹⁾	⁽¹⁾	Common Stock	7,120	⁽¹⁾	0	I	See Footnote 2.⁽²⁾

Explanation of Responses:

1. Each share of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, and Series C Convertible Preferred Stock (collectively, the "Preferred Stock") automatically converted on a 1-for-9.8821 basis into shares of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock had no expiration date.

2. Securities held by the Hasnain Revocable Trust.

	/s/ Jeffrey L. Boerneke, as Attorney-in-Fact	11/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR